News

Published on 1 May 2024 on Zacks via Yahoo Finance

Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates


Article preview image

Pfizer (PFE) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $1.23 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 46.43%. A quarter ago, it was expected that this drugmaker would post a loss of $0.19 per share when it actually produced earnings of $0.10, delivering a surprise of 152.63%.

NASDAQ.SPRB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic...

On Tuesday, Spruce Biosciences, Inc. (NASDAQ:SPRB) revealed topline results from its CAHmelia-204...

Benzinga · via Yahoo Finance 11 Dec 2024

Spruce Biosciences Reports Q3 2024 Earnings and Updates

Spruce Biosciences, Inc. ( (SPRB) ) has released its Q3 earnings. Here is a breakdown of the...

TipRanks · via Yahoo Finance 13 Nov 2024

Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop...

Spruce Biosciences Inc. (NASDAQ:SPRB) and HMNC Brain Health GmbH have collaborated to develop...

Benzinga · via Yahoo Finance 20 May 2024

Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates

Spruce Biosciences, Inc. (SPRB) came out with a quarterly loss of $0.28 per share versus the Zack...

Zacks via Yahoo Finance 12 May 2024

Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates

Pfizer (PFE) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Est...

Zacks via Yahoo Finance 1 May 2024

Novo Holdings sells shares of Spruce Biosciences for $351k By Investing.com

In a recent transaction, Novo Holdings A/S, a significant shareholder in Spruce Biosciences, Inc....

Investing.com 26 Mar 2024

Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why

Spruce Biosciences SPRB stock has declined 86.1% in the past month due to the failure of a key st...

Zacks via Yahoo Finance 24 Mar 2024

Revenue Downgrade: Here's What Analysts Forecast For Spruce Biosciences, Inc. (NASDAQ:SPRB)

The latest analyst coverage could presage a bad day for Spruce Biosciences, Inc. (NASDAQ:SPRB), w...

Simply Wall St. via Yahoo Finance 23 Mar 2024

Novo Holdings A/S unloads over $1.35 million in Spruce Biosciences stock By Investing.com

In a series of transactions this week, Novo Holdings A/S, a significant shareholder in Spruce ...

Investing.com 21 Mar 2024

Novo Holdings sells shares in Spruce Biosciences worth over $1.6 million By Investing.com

Novo Holdings sells shares in Spruce Biosciences worth over $1.6 million

Investing.com 19 Mar 2024